drugset
drugset / Trial / NCT03832699

Oral Dydrogesterone vs. Vaginal Micronized Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer

NCT03832699 ↗

Unknown 100 enrolled Wolfson Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The current trial is intended to assess the efficacy of oral versus vaginal progesterone for luteal support in frozen IVF cycles.

Timeline

Start
2019-03-01
Primary completion
2021-10
Completion
2021-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 10 mg Oral
Comparator Progesterone Other / unclassified 100 mg Other

Indications

No indication recorded.